GMED
Globus Medical, Inc. · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 80.59K | $4.78M | n/a | n/a |
| Q2 2026 | 123 | -3 | 71.27M | $5.66B | +7 | −9 |
| Q1 2026 | 128 | +3 | 69.73M | $6.00B | +7 | −5 |
| Q4 2025 | 125 | -2 | 72.17M | $6.30B | +1 | −2 |
| Q3 2025 | 23 | +2 | 41.89M | $2.40B | +2 | −1 |
| Q2 2025 | 19 | -2 | 35.55M | $2.10B | n/a | −2 |
| Q1 2025 | 18 | +2 | 12.57M | $919.97M | +3 | −1 |
| Q4 2024 | 16 | 0 | 17.69M | $1.46B | +1 | −1 |
| Q3 2024 | 15 | 0 | 11.77M | $842.11M | +1 | −1 |
| Q2 2024 | 15 | n/a | 12.93M | $885.43M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.21M | n/a | $219.83M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 2 | Geode Capital Management ✦ (passive) | 1.86M | n/a | $127.64M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 1.81M | n/a | $123.68M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.36M | n/a | $93.41M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.20M | n/a | $82.51M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Marshall Wace ✦ | 957.73K | n/a | $65.60M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 780.33K | n/a | $53.44M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 8 | Capital World Investors ✦ | 574.50K | n/a | $39.35M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 374.21K | n/a | $25.63M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 373.31K | n/a | $25.57M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | GAMCO Investors ✦ | 136.93K | n/a | $9.38M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Bridgewater Associates ✦ | 129.36K | n/a | $8.86M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 91.08K | n/a | $6.24M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | PRIMECAP Management ✦ | 47.52K | n/a | $3.25M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 15.24K | n/a | $1.04M | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 598 holders, 106.58M shares, $8.83B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 30.00K sh · $2.24M
Director · 25.00K sh · $2.18M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology